Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  López Ciudad, Víctor ^a   Castro Orjales, María Jose ^a   León, Cristóbal ^b   Sanz Rodríguez, César ^c   de la Torre Fernández, María Jose ^a   Pérez de Juan Romero, Miguel Angel ^a   Collell Llach, María Dolores ^a   Díaz López, María Dolores ^a  

^a Hospital Santa María Madre Complejo Hospitalario de Ourense   (Spain)

^b HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^c Medical affairs Merck sharp and Dohme ltd   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPICILLIN; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; KETOCONAZOLE; MEROPENEM; METICILLIN; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; VORICONAZOLE;

ABDOMINAL RADIOGRAPHY; ACUTE PANCREATITIS; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATION; BILIARY TRACT INFECTION; BLOOD CULTURE; CANDIDA PARAPSILOSIS; CASE REPORT; CHOLECYSTECTOMY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; ENDOCARDITIS; FEMALE; FOLLOW UP; FUNGAL DETECTION; FUNGAL STRAIN; FUNGUS CULTURE; FUNGUS IDENTIFICATION; HUMAN; HUMAN TISSUE; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; NEEDLE BIOPSY; NONHUMAN; OROPHARYNX CANDIDIASIS; PANCREAS BIOPSY; PANCREAS SURGERY; PARENTERAL NUTRITION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; CANDIDIASIS; DRUG THERAPY, COMBINATION; ECHINOCANDINS; ENDOCARDITIS; FEMALE; HUMANS; MIDDLE AGED; PEPTIDES, CYCLIC; PYRIMIDINES; TREATMENT OUTCOME; TRIAZOLES;

EID: 33646589312     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-73     Document Type: Article

References (26)

1. Pierrotti LC, Baddour LM: Fungal endocarditis, 1995-2000. Chest 2002, 122:302-310.
2. Bierbrier GS, Novick RJ, Guiraudon C, Wisenberg G, Boughner D: Left atrial bacterial mural endocarditis. Chest 1991, 99:757-759.
3. Kearney RA, Eisen HJ, Wolf JE: Nonvalvular infections of the cardiovascular system. Ann Intern Med 1994, 121:219-230.
4. Lang DM, Leisen JC, Elliott JP, Lewis JW Jr, Wendt DJ, Quinn EL: Echographically silent Aspergillus mural endocarditis. West J Med 1988, 149:334-338.
5. Mullen P, Jude C, Borkon M, Porterfield J, Walsh TJ: Aspergillus mural endocarditis. Clinical and echocardiographic diagnosis. Chest 1986, 90:451-452.
6. Walsh TJ, Hutchins GM: Aspergillus mural endocarditis. Am J Clin Pathol 1979, 71:640-644.
7. Lim ML, Oliver DH, Barasch E: Aspergillus mural vegetation identified by transesophageal echocardiography. Echocardiography 1997, 14:283-286.
8. Buchbinder NA, Roberts WC: Active infective endocarditis confined to mural endocardium. Arch Pathol 1972, 93:453-440.
9. Leung WH, Lau CP, Tai YT, Wong CK, Cheng CH: Candida right ventricular mural endocarditiscomplicating indwelling right arterial catheter. Chest 1990, 97:1492-1493.
10. Herzog CA, Carson P, Michaud L, Asinger R: Two-dimensional echocardiographic imaging of left ventricular mural vegetations. Am Heart J 1988, 115:684-686.
11. Tonomo K, Tsujino T, Fujioka Y, Nakao S, Yao H, Yasoshima H, Kubota A, Iwasaki T, Ohyanagi M: Candida parapsilosis endocarditis that emerged 2 years after abdominal surgery. Heart Vessels 2004, 19:149-152.
12. Tsao MMP, Katz D: Central venous catheter-induced endocarditis: human correlate of the animal experimental model of endocarditis. Rev Infect Dis 1984, 6:783-790.
13. Abi-Said K, Anaissie E, Uzum O, Raad I, Pinzcowski H, Vartivarian S: The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997, 24:1122-1128.
14. Weems JJ Jr. Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin Infect Dis 1992, 14:756-766.
15. Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, Lupinacci R, Sable C, Kartsonis N, Perfect J: Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002, 347:2020-2029.
16. Bacak V, Biocina B, Starcevic B, Gertler S, Begovac J: Candida albicans endocarditis Candida albicans endocarditis treatment with caspofungin in an HIV-infected patient-case report and review of literature. J Infect in press.
17. Lye DCB, Hughes A, O'Brien D, Athan E: Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review. Eur J Clin Microbial Infect Dis 2005, 24:753-755.
18. Rajendram R, Alp NJ, Mitchell AR, Bowler ICJW, Forfar JC: Candida prosthetic valve endocarditis cured by caspofungin therapy without valve replacement. Clin Infect Dis 2005, 40:e72-e74.
19. Jiménez-Expósito MJ, Torres G, Baradles A, Benito N, Marco F, Pare JC, Moreno A, Claramonte X, Mestres CA, Almela M, Garcia de la Maria C, Perez N, Schell WA, Corey GR, Perfect J, Jimenez de Anta MT, Gatell JM, Miro JM: Native valve endocarditis due to Candida glabrato treated without valvular replacement: a potential role of caspofungin in the induction and maintenance treatment. Clin Infect Dis 2004, 39:e70-e73.
20. Wertz KK, Pretzlaff RK: Caposfungin in a peadiatric patients with persistent candidemia. Pediatr Crit Care Med 2004, 5:181-183.
21. Bachmann SP, VandeWalle K, Ramage G, Patterson TF, Wickes BL, Graybill JR, Lopez-Ribot JL: In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 2002, 46:3591-3596.
22. Al-Fattani MA, Douglas LJ: Penetration of Candida biofilms by antifungal agents. Antimicrob Agents Chemother 2004, 48:3291-3297.
23. Kuhn DM, Ghannoum MA: Candida biofilms: antifungal resistance and emerging therapeutic options. Curr Opin Investig Drugs 2004, 5:186-197.
24. Damaj G, Ivanov V, Le Brigand B, D'incan E, Doglio MF, Bilger K, Faucher C, Vey N, Gastaut JA: Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient. Ann Hematol 2004, 83:390-393.
25. Schuster F, Moelter C, Schmid I, Graubner UB, Kammer B, Belohradsky BH, Fuhrer M: Successful antifungal combination therapy with voriconazole and caspofungin. Pediatr Blood Cancer 2005, 44:682-685.
26. Breit SM, Hariprasad SM, Mieler WF, Shah GK, Mills MD, Grand MG: Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol 2005, 139:135-140.